ArticleRSC advances2025
Electrospun poly(ε-caprolactone)/silver nanoparticle nanofibrous scaffolds with antibacterial activity for wound-dressing applications.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Comparative analysis of traditional and smart antibacterial textiles for wearable technology; a comprehensive review.RSC advances · 2026Review
- Printing to Fight Antimicrobial Resistance Through Nano/Microstructured Platforms.Chemical record (New York, N.Y.) · 2026Review
- Advanced Antibacterial Nanocomposite Fibers for Biomedical Applications.Pharmaceutics · 2026Article
- Modified Polycaprolactone Films for Temporary Protection in Saline Conditions: A Preliminary Assessment.Polymers · 2025Article
- Silver integrated hybrids and nanocomposites for next-generation biomedicine: Beyond antimicrobial coatings toward smart sense-response-heal platforms.Materials today. Bio · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silver nanoparticle (AgNP)-based nanofibers are widely used in biomedical applications for their broad-spectrum activity and biocompatibility. This study aims to biofabricate and characterize electrospun polycaprolactone (PCL) nanofibers loaded with biosynthesized AgNPs, with the goal of evaluating their structural properties and antibacterial effectiveness for potential use in antibacterial wound-dressing applications. The biosynthesis of AgNPs was achieved using an aqueous extract of Piper nigrum leaves. Nanocomposite membranes at different AgNP concentrations (0.04, 0.4, and 1 wt%) were prepared to investigate their physicochemical and antibacterial properties. Morphological characterization confirmed bead-free, continuous fiber formation, with reduced fiber diameters upon increasing AgNP content. AFM results revealed enhanced surface roughness. FTIR spectra indicated improved hydrophilicity and successful chemical incorporation of AgNPs. Mechanical testing demonstrated increased tensile strength at 0.4 wt% AgNPs, followed by a decline due to nanoparticle agglomeration at 1 wt%. Contact angle measurements confirmed a significant shift toward hydrophilicity with higher AgNP concentrations. Antibacterial assays revealed strong inhibition against
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.